Biolase

Biolase

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $10M

Overview

Biolase is a pioneering commercial-stage company in the dental laser device sector, known for its flagship Waterlase all-tissue laser systems. The company has recently been acquired by MegaGen, a move intended to reinvigorate product quality and customer support under new leadership. Biolase's business model combines the sale of advanced laser equipment with comprehensive education, training, and service, targeting dental practices seeking to adopt minimally invasive dentistry.

Dentistry

Technology Platform

Proprietary HydroPhotonics® technology combining laser energy and water for minimally invasive hard and soft tissue dental procedures.

Funding History

2
Total raised:$10M
PIPE$10M
IPOUndisclosed

Opportunities

The acquisition by MegaGen provides access to a global implant sales channel for cross-selling lasers.
Growing patient and dentist demand for minimally invasive procedures expands the total addressable market.
The dedicated hygienist laser (Epic Hygiene) opens a new customer segment within existing dental practices.

Risk Factors

Intense competition in the dental laser market threatens pricing and market share.
Successful integration and synergy realization with new parent company MegaGen is not guaranteed.
High capital cost and required training remain adoption barriers for some dental practices.

Competitive Landscape

Biolase competes in the global dental laser market against companies like Fotona (Er:YAG and Nd:YAG lasers), AMD Lasers (a Dentsply Sirona company), and other diode laser manufacturers. Its key differentiation is its all-tissue capability with the Waterlase system. The landscape is characterized by continuous technological innovation and a strong emphasis on clinical education and practice support.